pubrio
Asymchem logo

Asymchem

Public
asymchem.com
制药行业700+ employeesFounded 1999🇨🇳 中国

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

成立年份
1999
员工人数
700+
行业
制药行业
公司类型
Public Company
股票
sse: 06821.HK
总部
🇨🇳6 Dongting 3rd Avenue, Teda, Tianjin Municipality, Cn, 300457 (+9)
专长
制药行业生物技术化学制造
2 / 3
活跃市场
0
新市场
置信度
多为早期信号
+1000%
势头
较上一周期
33 / 100
扩张评分
发展中
阶段3投入中
12 个信号 · 最近 90 天

全球扩张

实时
USGBIN
阶段
探索中投入中进入中运营中

活动脉搏

新增 营销与公关 活动 — 刚出现 11 个新信号。

最近 90 天
招聘
1已结束
招聘
营销与公关
11新增
广告投放
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇺🇸US进入的第 1st 个市场 · 2012推进中
投入中
16 个信号投入中 阶段
2
🇬🇧GB进入的第 2nd 个市场 · 2024推进中
投入中
14 个信号投入中 阶段
3
🇮🇳IN进入的第 3rd 个市场 · 2025推进中
投入中
1 个信号投入中 阶段
当前阶段投入中投入资源
置信度33%
开始追踪于2012首个信号

近期信号

广告投放🇵🇹 PT4周前

Asymchem Basel Symposium

广告投放🇺🇸 US4周前

Asymchem Basel Symposium

注册以查看完整信号动态

了解一下

关于 Asymchem 的常见问题

关于 Asymchem 的业务、市场和增长信号的快速解答。

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。